Money Racket — See who Washington just made rich.
The Brief
Who just cashed inFDA Authorizes CLiK Extra for Screwworm Prevention in Livestock and Wildlife—Direct Beneficiary Unclear, Supplier Play Emerges
The FDA issued an Emergency Use Authorization on August 7, 2026, for CLiK Extra (dicyclanil topical suspension) to prevent New World screwworm infestations in sheep, cattle, goats, swine, camelids, and certain wildlife species. The product is a wound spray applied directly to wounds to block screwworm infestation.
Why it matters — The text does not name the manufacturer of CLiK Extra. However, the authorization creates immediate demand for wound-care and animal-health distribution channels. Distributors of veterinary pharmaceuticals and livestock health products—including companies like Covetrus (CVET), which supplies veterinary practices and livestock operations, and Tractor Supply (TSCO), which sells animal health products to ranchers—stand to benefit from increased screwworm-prevention product sales. Zoetis (ZTS), the largest animal-health company, may also see indirect benefit if it gains distribution rights or develops competing products. The authorization is real and urgent (screwworm is spreading in Texas and New Mexico), but the direct manufacturer remains unnamed in the text.
FDA Approves Tudriqev for Refractory Melanoma—Oncology Combination Play with Nivolumab
The FDA granted accelerated approval on August 6, 2026, to Tudriqev (vusolimogene oderparepvec-wtpg), a genetically modified oncolytic viral therapy, for advanced melanoma in combination with nivolumab (a PD-1 inhibitor) in patients who have progressed on prior PD-1 therapy. One in four patients responded, with median response duration of 14 months.
Kimberly-Clark Secures $45M Tariff Refund—Partial Recovery on 2025 Tariff Exposure
Kimberly-Clark (KMB) secured a $45 million tariff refund, representing roughly half of the tariffs it paid in 2025, according to Supply Chain Dive reporting on August 2026 tariff refund flows.
Trump Executive Order on Childhood Vaccine Schedule—Potential Demand Shift Away from Combination Vaccines
President Trump signed an executive order in August 2026 calling for spacing out childhood vaccines and seeking to split combination vaccines (notably MMR) into separate shots, contrary to guidance from major medical organizations including the CDC and American Academy of Pediatrics.
Our sharpest breakdowns: the stocks whose real driver is a policy nobody's pricing in. Start here.
Defense
Why L3Harris Is Really a Policy Stock, Not a Hardware Stock
L3Harris's Aerojet Rocketdyne deal turned it into a solid-rocket-motor gatekeeper right as the Pentagon's munitions-replenishment push makes propulsion, not platforms, the real budget chokepoint.
Energy
Why Constellation (CEG) Is Really a Policy Stock, Not a Utility Stock
Strip out the DOE loan, the production tax credit, and the Microsoft power deal, and Constellation's valuation stops making sense as a regulated utility — it only works as a Washington bet.
Tech
The Real Beneficiary of Chip Export Controls Isn't Nvidia — It's the Hyperscalers' Custom Silicon
Every BIS tightening on GPU sales to China is a subsidy for the in-house chip programs at Amazon, Google, and Microsoft — and for the fab and packaging suppliers who build them.
Healthcare
Why UNH Is Really a Policy Stock, Not a Health Insurer
CMS rate notices and star-rating bonuses swing UnitedHealth's earnings more than any hospital admission ever will — and the same mechanism is now a two-way street for the whole Medicare Advantage complex.
Finance
Why Schwab Is Secretly a Fed Funds Rate Stock, Not a Brokerage Stock
SCHW's earnings power now hinges on net interest margin from client cash sweeps and its bank balance sheet — meaning the FOMC's pace, not trading volume, is the real catalyst investors should be watching.
Markets
Why MP Materials Is Really a Defense Stock Wearing an EV Costume
The Pentagon is now MP Materials' largest shareholder, its price-floor customer, and its bank — which means the stock trades on defense budgets and China export curbs, not Tesla's delivery numbers.
Tech
Washington's Secure-by-Design Mandate Is Quietly Picking Cybersecurity's Winner
EO 14306's push for consolidated, SBOM-verified software supply chains rewards vendors selling one platform over agencies juggling a dozen point tools — and that math favors Palo Alto over CrowdStrike, for now.
Crypto
Why Coinbase Is a Licensing Moat Wearing a Trading-Volume Costume
Federal crypto market-structure legislation doesn't disrupt the industry's incumbent — it codifies the licensing stack Coinbase already spent a decade building.
Defense
IonQ Lands $28M U.S. Defense Quantum Contract
Trapped-ion quantum startup wins federal validation and revenue for defense applications.
Healthcare & FDA
FDA Clears Screwworm Prevention Drug for U.S. Livestock
Emergency authorization for CLiK Extra opens market for wound-care products in agriculture.
Energy
NRC Approves NAC MAGNASTOR Spent Fuel Storage Cask
Regulatory clearance for advanced nuclear waste storage technology.
Healthcare & FDA
FDA Updates Fresh-Cut Produce Safety Guidance
New standards tighten biological hazard controls for manufacturers.
White House
Trump Orders Childhood Vaccine Schedule Spacing
Executive order calls for spreading out shots, creating demand uncertainty.
White House
Trump Order Splits MMR Vaccine—Pharma Faces Demand Shift
Executive order to space out childhood shots and separate combination vaccines reshapes immunization market.
Defense
Trump Pushes $1.5T Defense Budget—Lockheed, RTX, GD Lock in Gains
Massive spending increase flows directly to prime contractors and their supply chains.
White House
White House Drafts Vaccine-Autism Order—Pharma Faces Uncertainty
Executive order linking vaccines and autism could undermine immunization rates and vaccine demand.
Tech
Trump Administration Adds 6 Chipmakers to U.S. Portfolio
Government stock purchases signal long-term commitment to domestic semiconductor supply chain.
Get a free alert when Washington's next move mints a winner.
We'll email you when a White House order, a federal contract, or an FDA decision hands a public company a windfall — with who benefits. No spam, unsubscribe in one click.
Free · weekly · unsubscribe anytime. Privacy.
Primary sources. Named winners. Verified before it runs.
How Defense Appropriations Become Prime-Contractor Revenue
Congress doesn't just fund the Pentagon — it pre-books years of revenue for a small club of public companies, and the paper trail from bill to backlog is public if you know where to look.
TrackerData Centers and the AI-Power Grid Trade
Washington is rewriting U.S. energy policy around AI compute demand — here is how to trace the money from federal decision to public market winner.
TrackerThe Homebuilder Trade Through a Rate Cycle
How Federal Reserve rate policy moves through mortgage rates into homebuilder earnings, and the real tickers positioned on both sides of that transmission belt.